What does "PHARMACIE PENNINCK" do?

"PHARMACIE PENNINCK" is a pharmacy in Mons. Private Limited, started on 9 June 2022, 1 establishment.

What is the address of "PHARMACIE PENNINCK"?

The registered office of "PHARMACIE PENNINCK" is located at Av. Champ de Bataille (Jem. II) 483, 7012 Mons.

Is "PHARMACIE PENNINCK" still active?

Yes. According to the CBE (1 October 2026) "PHARMACIE PENNINCK" is active, legal situation “Normale toestand”, started on 9 June 2022.

Is "PHARMACIE PENNINCK" registered on Peppol?

Yes, "PHARMACIE PENNINCK" is registered on the Peppol network with ID 0208:0786972183.

What is the enterprise number of "PHARMACIE PENNINCK"?

The enterprise number of "PHARMACIE PENNINCK" is BE0786972183.

When was "PHARMACIE PENNINCK" founded?

"PHARMACIE PENNINCK" was founded on 9 June 2022.

Who are the directors of "PHARMACIE PENNINCK"?

According to the 2025 annual accounts, the directors of "PHARMACIE PENNINCK" are: LAURENCE PENNINCK.

Is "PHARMACIE PENNINCK" a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 June 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did "PHARMACIE PENNINCK" make in 2025?

"PHARMACIE PENNINCK" posted a profit after taxes of € 67,640 in financial year 2025.

What is the revenue of "PHARMACIE PENNINCK"?

As a small company, "PHARMACIE PENNINCK" is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 178,479.

How many employees does "PHARMACIE PENNINCK" have?

According to the 2025 annual accounts, "PHARMACIE PENNINCK" has 0.1 full-time equivalents (FTE).

"PHARMACIE PENNINCK" (Private Limited) - Mons

Dossier "PHARMACIE PENNINCK", printed on 1 October 2026 from databakkes.be/en/0786972183/pharmacie-penninck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 45 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

"PHARMACIE PENNINCK" from Mons, company number BE0786972183, closed financial year 2025 with a result of € 67,640 after tax. For that financial year "PHARMACIE PENNINCK" recorded a gross margin of € 178,479 and equity of € 73,000. Compared with financial year 2024, the result moved from € 59,366 to € 67,640. Profitable, and profit is growing. The buffer shrank hard: equity is 59 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Shrank hard

€ 73,000

▼ 59% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 67,640

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 93,894

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 173,518 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0.1

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 5,872

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 29,766

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 464,961

▼ 9% vs 2024

€ 49,876 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 38,837

▼ 53% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 8,565

▼ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 63,026 Gross margin 2022: € 63,026 First fiscal year in the series	€ 119,783 Gross margin 2023: € 119,783 ▲ 90% vs 2022 (€ 63,026) Favourable step	€ 164,187 Gross margin 2024: € 164,187 ▲ 37% vs 2023 (€ 119,783) Favourable step	€ 178,479 Gross margin 2025: € 178,479 ▲ 9% vs 2024 (€ 164,187) Favourable step	▲ 9%
Profit after taxes	€ 20,084 Profit after taxes 2022: € 20,084 First fiscal year in the series	€ 31,360 Profit after taxes 2023: € 31,360 ▲ 56% vs 2022 (€ 20,084) Favourable step	€ 59,366 Profit after taxes 2024: € 59,366 ▲ 89% vs 2023 (€ 31,360) Favourable step	€ 67,640 Profit after taxes 2025: € 67,640 ▲ 14% vs 2024 (€ 59,366) Favourable step	▲ 14%
Equity	€ 26,785 Equity 2022: € 26,785 First fiscal year in the series	€ 120,345 Equity 2023: € 120,345 ▲ € 93,559 vs 2022 (€ 26,785) Favourable step	€ 178,878 Equity 2024: € 178,878 ▲ 49% vs 2023 (€ 120,345) Favourable step	€ 73,000 Equity 2025: € 73,000 ▼ 59% vs 2024 (€ 178,878) Unfavourable step	▼ 59%
Total debts	€ 695,205 Total debts 2022: € 695,205 First fiscal year in the series	€ 800,891 Total debts 2023: € 800,891 ▲ 15% vs 2022 (€ 695,205) Unfavourable step	€ 729,492 Total debts 2024: € 729,492 ▼ 9% vs 2023 (€ 800,891) Favourable step	€ 770,339 Total debts 2025: € 770,339 ▲ 6% vs 2024 (€ 729,492) Unfavourable step	▲ 6%
Cash	€ 120,322 Cash 2022: € 120,322 First fiscal year in the series	€ 116,971 Cash 2023: € 116,971 ▼ 3% vs 2022 (€ 120,322) Unfavourable step	€ 79,752 Cash 2024: € 79,752 ▼ 32% vs 2023 (€ 116,971) Unfavourable step	€ 93,894 Cash 2025: € 93,894 ▲ 18% vs 2024 (€ 79,752) Favourable step	▲ 18%
Land & buildings	€ 180,508 Land & buildings 2022: € 180,508 First fiscal year in the series	€ 351,761 Land & buildings 2023: € 351,761 ▲ 95% vs 2022 (€ 180,508) Unchanged	€ 339,424 Land & buildings 2024: € 339,424 ▼ 4% vs 2023 (€ 351,761) Unchanged	€ 322,936 Land & buildings 2025: € 322,936 ▼ 5% vs 2024 (€ 339,424) Unchanged	▼ 5%
Retained profit	€ 16,784 Retained profit 2022: € 16,784 First fiscal year in the series	€ 47,345 Retained profit 2023: € 47,345 ▲ 182% vs 2022 (€ 16,784) Favourable step	€ 105,878 Retained profit 2024: € 105,878 ▲ 124% vs 2023 (€ 47,345) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 105,878) Unfavourable step	▼ 100%
Dividend	€ 3,300 Dividend 2022: € 3,300 First fiscal year in the series	€ 800 Dividend 2023: € 800 ▼ 76% vs 2022 (€ 3,300) Unchanged	€ 833 Dividend 2024: € 833 ▲ 4% vs 2023 (€ 800) Unchanged	€ 173,518 Dividend 2025: € 173,518 ▲ € 172,685 vs 2024 (€ 833) Unchanged	▲ € 172,685
Bank debt	€ 392,480 Bank debt 2022: € 392,480 First fiscal year in the series	€ 557,731 Bank debt 2023: € 557,731 ▲ 42% vs 2022 (€ 392,480) Unfavourable step	€ 513,289 Bank debt 2024: € 513,289 ▼ 8% vs 2023 (€ 557,731) Favourable step	€ 464,961 Bank debt 2025: € 464,961 ▼ 9% vs 2024 (€ 513,289) Favourable step	▼ 9%
Balance sheet total	€ 721,990 Balance sheet total 2022: € 721,990 First fiscal year in the series	€ 921,235 Balance sheet total 2023: € 921,235 ▲ 28% vs 2022 (€ 721,990) Unchanged	€ 908,369 Balance sheet total 2024: € 908,369 ▼ 1% vs 2023 (€ 921,235) Unchanged	€ 843,339 Balance sheet total 2025: € 843,339 ▼ 7% vs 2024 (€ 908,369) Unchanged	▼ 7%
Employees (FTE)	-	-	0 Employees (FTE) 2024: 0 First fiscal year in the series	0.1 Employees (FTE) 2025: 0.1 Unchanged (0) Unchanged

Key figures of "PHARMACIE PENNINCK", fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to "PHARMACIE PENNINCK"?

What happened at "PHARMACIE PENNINCK" in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 67,640 (▲ 14% vs 2024). Source: NBB ↗
Jun 9, 2022 New establishment in Mons. KBO
Jun 9, 2022 Start of the company according to the CBE. KBO
2022 LAURENCE PENNINCK became a director. NBB

In short

From € 20,084 profit in 2022 to € 67,640 profit in 2025.

Paid € 45,854 in corporate taxes since 2022.

Best year ever: 2025, with € 67,640 profit.

Paid out € 178,451 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at "PHARMACIE PENNINCK"? We notify you, reason included.

Follow "PHARMACIE PENNINCK"

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LAURENCE PENNINCK

"PHARMACIE PENNINCK"

Behind "PHARMACIE PENNINCK" is LAURENCE PENNINCK.

See the full network in the app

Directors

According to the 2025 annual accounts

LAURENCE PENNINCK

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Av. Champ de Bataille (Jem. II) 483

7012 Mons

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0786.972.183
VAT number: BE 0786.972.183
Registered office: Av. Champ de Bataille (Jem. II) 483, 7012 Mons
Names & denominations: "PHARMACIE PENNINCK"
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 June 2022
Peppol: Active · Active since 15 Sept 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗